Delayed first injection of the once-a-month injectable contraceptive containing 25 mg of medroxyprogesterone acetate and 5 mg of E2-cypionate: Effects on ovarian function

Fertility and Sterility

Volumn 75, Issue 4, 2001, Pages 744-748

  Petta, Carlos Alberto ^a   Hays, Melissa ^b   Brache, Vivian ^c   Massai, Rebeca ^d   Hua, Yang ^e   Alvarez Sánchez, Francisco ^c   Croxatto, Horacio ^d   D'Arcangues, Catherine ^f   Cook, Lynley A ^b   Bahamondes, Luis ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FAMILY HEALTH INTERNATIONAL   (United States)

^c PROFAMILIA   (Dominican Republic)

^d Instituto Chileno de Medicina Reproductiva   (Chile)

^e INSTITUTE OF MATERIA MEDICA   (China)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Contraception; Cyclofem; Ovulation; Progesterone; Randomized controlled trial; Ultrasound

Indexed keywords

ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; INJECTABLE CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; MULTICENTER STUDY; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND;

ADOLESCENT; ADULT; AGE FACTORS; BODY MASS INDEX; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; ESTRADIOL; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUAL CYCLE; OVARIAN FOLLICLE; OVARY; OVULATION; PROGESTERONE;

EID: 0035075506     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)01672-7     Document Type: Article

References (11)

1. Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru
2. Ultrasound in the evaluation of normal and induced ovulation
3. Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development
4. A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera. World Health Organization Task Force on Long-acting Systemic Agents for Fertility Regulation
5. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function
6. Timing of onset of contraceptive effectiveness in Norplant implant users. II. Effect on the ovarian function in the first cycle of use
7. Luteal phase defect; the sensitivity and specificity of diagnostic methods in common clinical use
8. Population and delivery systems; variability in pharmacokinetics of long-acting injectable contraceptives